Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1–3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis
Breast Cancer · 2026-07 · 33 (4) · 928-937
DOI: 10.1007/s12282-026-01871-2 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Breast Cancer, online erschienen am 23.05.2026. Verfasst von Takeshi Murata und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tamurata@ncc.go.jp. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Micrometastasis, Erb-b2 Receptor Tyrosine Kinases, Lymph Nodes. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. tamurata@ncc.go.jp.
- Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo- ku, Tokyo, 104-0045, Japan.
- Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Zitieren
APA
Murata, T., Yoshida, M., Watase, C., Maeda, H., Nakashoji, A., Ogawa, A., Ohgi, N., Chen, M., Tsubota, S., Maeshima, A., Iwamoto, E., & Takayama, S. (2026). Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1–3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis. Breast Cancer, 33(4), 928-937. https://doi.org/10.1007/s12282-026-01871-2
Vancouver
Murata T, Yoshida M, Watase C, Maeda H, Nakashoji A, Ogawa A, et al. Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1–3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis. Breast Cancer. 2026;33(4):928-937. doi:10.1007/s12282-026-01871-2
BibTeX
@article{Murata2026,
author = {Murata, Takeshi and Yoshida, Masayuki and Watase, Chikashi and Maeda, Hinako and Nakashoji, Ayako and Ogawa, Ayumi and Ohgi, Natsuko and Chen, Mengge and Tsubota, Sayako and Maeshima, Akiko and Iwamoto, Eriko and Takayama, Shin},
title = {Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1–3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis},
journal = {Breast Cancer},
year = {2026},
volume = {33},
number = {4},
pages = {928--937},
doi = {10.1007/s12282-026-01871-2}
}
EUVIMED